LinkedIn Profile

Access Axsome Therapeutics historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
nasdaq:axsm 6553282 Apr 21st, 2024 12:00AM Axsome Therapeutics, Inc. 22K 528.00 Open Apr 20th, 2024 10:59PM Apr 20th, 2024 10:59PM Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for central nervous system (CNS) conditions that have limited treatment options. Through development of therapeutic options with novel mechanisms of action, we are transforming the approach to treating CNS conditions. At Axsome, we are intensely committed to developing products that meaningfully improve the lives of patients and provide additional therapeutic options for physicians. Open Biopharmaceuticals, Pain, CNS, Narcolepsy, Major Depressive Disorder, Alzheimer's Disease Agitation, Fibromyalgia, Smoking Cessation, Migraine, and Attention Deficit Hyperactivity Disorder Open One World Trade Center New York NY US 10007 Axsome Therapeutics
nasdaq:axsm 6553282 Apr 20th, 2024 12:00AM Axsome Therapeutics, Inc. 22K 528.00 Open Apr 19th, 2024 10:58PM Apr 20th, 2024 04:37PM Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for central nervous system (CNS) conditions that have limited treatment options. Through development of therapeutic options with novel mechanisms of action, we are transforming the approach to treating CNS conditions. At Axsome, we are intensely committed to developing products that meaningfully improve the lives of patients and provide additional therapeutic options for physicians. Open Biopharmaceuticals, Pain, CNS, Narcolepsy, Major Depressive Disorder, Alzheimer's Disease Agitation, Fibromyalgia, Smoking Cessation, Migraine, and Attention Deficit Hyperactivity Disorder Open One World Trade Center New York NY US 10007 Axsome Therapeutics
nasdaq:axsm 6553282 Apr 19th, 2024 12:00AM Axsome Therapeutics, Inc. 22K 526.00 Open Apr 18th, 2024 11:07PM Apr 18th, 2024 11:07PM Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for central nervous system (CNS) conditions that have limited treatment options. Through development of therapeutic options with novel mechanisms of action, we are transforming the approach to treating CNS conditions. At Axsome, we are intensely committed to developing products that meaningfully improve the lives of patients and provide additional therapeutic options for physicians. Open Biopharmaceuticals, Pain, CNS, Narcolepsy, Major Depressive Disorder, Alzheimer's Disease Agitation, Fibromyalgia, Smoking Cessation, Migraine, and Attention Deficit Hyperactivity Disorder Open One World Trade Center New York NY US 10007 Axsome Therapeutics
nasdaq:axsm 6553282 Apr 18th, 2024 12:00AM Axsome Therapeutics, Inc. 22K 526.00 Open Apr 17th, 2024 11:04PM Apr 18th, 2024 05:57PM Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for central nervous system (CNS) conditions that have limited treatment options. Through development of therapeutic options with novel mechanisms of action, we are transforming the approach to treating CNS conditions. At Axsome, we are intensely committed to developing products that meaningfully improve the lives of patients and provide additional therapeutic options for physicians. Open Biopharmaceuticals, Pain, CNS, Narcolepsy, Major Depressive Disorder, Alzheimer's Disease Agitation, Fibromyalgia, Smoking Cessation, Migraine, and Attention Deficit Hyperactivity Disorder Open One World Trade Center New York NY US 10007 Axsome Therapeutics
nasdaq:axsm 6553282 Apr 17th, 2024 12:00AM Axsome Therapeutics, Inc. 22K 526.00 Open Apr 16th, 2024 10:51PM Apr 17th, 2024 02:21PM Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for central nervous system (CNS) conditions that have limited treatment options. Through development of therapeutic options with novel mechanisms of action, we are transforming the approach to treating CNS conditions. At Axsome, we are intensely committed to developing products that meaningfully improve the lives of patients and provide additional therapeutic options for physicians. Open Biopharmaceuticals, Pain, CNS, Narcolepsy, Major Depressive Disorder, Alzheimer's Disease Agitation, Fibromyalgia, Smoking Cessation, Migraine, and Attention Deficit Hyperactivity Disorder Open One World Trade Center New York NY US 10007 Axsome Therapeutics
nasdaq:axsm 6553282 Apr 16th, 2024 12:00AM Axsome Therapeutics, Inc. 22K 526.00 Open Apr 15th, 2024 10:45PM Apr 16th, 2024 10:37AM Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for central nervous system (CNS) conditions that have limited treatment options. Through development of therapeutic options with novel mechanisms of action, we are transforming the approach to treating CNS conditions. At Axsome, we are intensely committed to developing products that meaningfully improve the lives of patients and provide additional therapeutic options for physicians. Open Biopharmaceuticals, Pain, CNS, Narcolepsy, Major Depressive Disorder, Alzheimer's Disease Agitation, Fibromyalgia, Smoking Cessation, Migraine, and Attention Deficit Hyperactivity Disorder Open One World Trade Center New York NY US 10007 Axsome Therapeutics
nasdaq:axsm 6553282 Apr 15th, 2024 12:00AM Axsome Therapeutics, Inc. 22K 526.00 Open Apr 14th, 2024 10:46PM Apr 15th, 2024 04:18PM Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for central nervous system (CNS) conditions that have limited treatment options. Through development of therapeutic options with novel mechanisms of action, we are transforming the approach to treating CNS conditions. At Axsome, we are intensely committed to developing products that meaningfully improve the lives of patients and provide additional therapeutic options for physicians. Open Biopharmaceuticals, Pain, CNS, Narcolepsy, Major Depressive Disorder, Alzheimer's Disease Agitation, Fibromyalgia, Smoking Cessation, Migraine, and Attention Deficit Hyperactivity Disorder Open One World Trade Center New York NY US 10007 Axsome Therapeutics
nasdaq:axsm 6553282 Apr 14th, 2024 12:00AM Axsome Therapeutics, Inc. 22K 525.00 Open Apr 13th, 2024 10:39PM Apr 14th, 2024 10:37AM Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for central nervous system (CNS) conditions that have limited treatment options. Through development of therapeutic options with novel mechanisms of action, we are transforming the approach to treating CNS conditions. At Axsome, we are intensely committed to developing products that meaningfully improve the lives of patients and provide additional therapeutic options for physicians. Open Biopharmaceuticals, Pain, CNS, Narcolepsy, Major Depressive Disorder, Alzheimer's Disease Agitation, Fibromyalgia, Smoking Cessation, Migraine, and Attention Deficit Hyperactivity Disorder Open One World Trade Center New York NY US 10007 Axsome Therapeutics
nasdaq:axsm 6553282 Apr 13th, 2024 12:00AM Axsome Therapeutics, Inc. 22K 525.00 Open Apr 12th, 2024 10:30PM Apr 13th, 2024 11:05AM Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for central nervous system (CNS) conditions that have limited treatment options. Through development of therapeutic options with novel mechanisms of action, we are transforming the approach to treating CNS conditions. At Axsome, we are intensely committed to developing products that meaningfully improve the lives of patients and provide additional therapeutic options for physicians. Open Biopharmaceuticals, Pain, CNS, Narcolepsy, Major Depressive Disorder, Alzheimer's Disease Agitation, Fibromyalgia, Smoking Cessation, Migraine, and Attention Deficit Hyperactivity Disorder Open One World Trade Center New York NY US 10007 Axsome Therapeutics
nasdaq:axsm 6553282 Apr 12th, 2024 12:00AM Axsome Therapeutics, Inc. 22K 525.00 Open Apr 11th, 2024 10:33PM Apr 12th, 2024 08:00AM Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for central nervous system (CNS) conditions that have limited treatment options. Through development of therapeutic options with novel mechanisms of action, we are transforming the approach to treating CNS conditions. At Axsome, we are intensely committed to developing products that meaningfully improve the lives of patients and provide additional therapeutic options for physicians. Open Biopharmaceuticals, Pain, CNS, Narcolepsy, Major Depressive Disorder, Alzheimer's Disease Agitation, Fibromyalgia, Smoking Cessation, Migraine, and Attention Deficit Hyperactivity Disorder Open One World Trade Center New York NY US 10007 Axsome Therapeutics

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.